Statement on Measles-Mumps-Rubella-Varicella Vaccine: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
作者信息
Tan Ben, Ismail Shainoor
出版信息
Can Commun Dis Rep. 2010 Sep 21;36(ACS-9):1-22. doi: 10.14745/ccdr.v36i00a09.
Abstract
摘要
相似文献
1
Statement on Measles-Mumps-Rubella-Varicella Vaccine: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Can Commun Dis Rep. 2010 Sep 21;36(ACS-9):1-22. doi: 10.14745/ccdr.v36i00a09.
2
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.
3
Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.
4
Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Can Commun Dis Rep. 2010 Sep 20;36(ACS-8):1-26. doi: 10.14745/ccdr.v36i00a08.
5
Literature Review on One-Dose and Two-Dose Varicella Vaccination: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Can Commun Dis Rep. 2010 Oct 18;36(ACS-10):1-24. doi: 10.14745/ccdr.v36i00a10.
6
Updated Recommendations for the Use of Varicella and MMR Vaccines In HIV-Infected Individuals: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Can Commun Dis Rep. 2010 Sep 16;36(ACS-7):1-19. doi: 10.14745/ccdr.v36i00a07.
7
Statement on Seasonal Influenza Vaccine for 2011-2012: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Can Commun Dis Rep. 2011 Oct 14;37(ACS-5):1-55. doi: 10.14745/ccdr.v37i00a05.
8
STATEMENT ON THE RECOMMENDED USE OF HERPES ZOSTER VACCINE: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)*.
Can Commun Dis Rep. 2010 Jan 25;36(ACS-1):1-19. doi: 10.14745/ccdr.v36i00a01.
9
Recommendations on the use of live, attenuated influenza vaccine (FluMist): Supplemental Statement on Seasonal Influenza Vaccine for 2011-2012 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Can Commun Dis Rep. 2011 Nov 30;37(ACS-7):1-77. doi: 10.14745/ccdr.v37i00a07.
10
Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Can Commun Dis Rep. 2010 Aug 31;36(ACS-6):1-49. doi: 10.14745/ccdr.v36i00a06.
引用本文的文献
1
Assessing safety of Ontario's publicly funded MMR and MMRV immunization programs, 2012 to 2016.
Paediatr Child Health. 2019 Apr 8;25(6):358-364. doi: 10.1093/pch/pxz037. eCollection 2020 Oct.
2
GUIDELINES FOR THE PREVENTION AND CONTROL OF MEASLES OUTBREAKS IN CANADA: An Advisory Committee Statement (ACS) Measles and Rubella Elimination Working Group (MREWG).
Can Commun Dis Rep. 2013 Oct 30;39(ACS-3):1-52. doi: 10.14745/ccdr.v39i00a03.
3
Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Can Commun Dis Rep. 2010 Sep 20;36(ACS-8):1-26. doi: 10.14745/ccdr.v36i00a08.
4
Measles surveillance in Canada: Trends for 2013.
Can Commun Dis Rep. 2014 Jun 12;40(12):219-232. doi: 10.14745/ccdr.v40i12a01.
5
Immunization in Canada: Update for 2015.
J Can Chiropr Assoc. 2016 Mar;60(1):6-12.
6
Conflicting health information: a critical research need.
Health Expect. 2016 Dec;19(6):1173-1182. doi: 10.1111/hex.12438. Epub 2015 Dec 28.
7
Measles in Canada Between 2002 and 2013.
Open Forum Infect Dis. 2015 Apr 15;2(2):ofv048. doi: 10.1093/ofid/ofv048. eCollection 2015 Apr.
8
Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study.
CMAJ. 2014 Aug 5;186(11):824-9. doi: 10.1503/cmaj.140078. Epub 2014 Jun 9.
9
Measles.
CMAJ. 2012 Nov 6;184(16):1811. doi: 10.1503/cmaj.111574. Epub 2012 May 28.
本文引用的文献
1
Literature Review on One-Dose and Two-Dose Varicella Vaccination: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Can Commun Dis Rep. 2010 Oct 18;36(ACS-10):1-24. doi: 10.14745/ccdr.v36i00a10.
2
Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Can Commun Dis Rep. 2010 Sep 20;36(ACS-8):1-26. doi: 10.14745/ccdr.v36i00a08.
3
Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months.
Pediatr Infect Dis J. 2010 Jun;29(6):e47-56. doi: 10.1097/INF.0b013e3181dffabf.
4
Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months.
Eur J Pediatr. 2010 Aug;169(8):925-33. doi: 10.1007/s00431-010-1142-6. Epub 2010 Feb 11.
5
A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile.
Vaccine. 2009 Nov 5;27(47):6504-11. doi: 10.1016/j.vaccine.2009.07.076. Epub 2009 Aug 7.
6
An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients--Arkansas, 2006.
Pediatr Infect Dis J. 2009 Aug;28(8):678-81. doi: 10.1097/INF.0b013e31819c1041.
7
Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting.
Vaccine. 2009 Jul 23;27(34):4656-61. doi: 10.1016/j.vaccine.2009.05.056. Epub 2009 Jun 9.
8
Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
Vaccine. 2009 May 5;27(20):2701-6. doi: 10.1016/j.vaccine.2009.02.044. Epub 2009 Feb 24.
9
Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
Vaccine. 2009 Jan 14;27(3):446-53. doi: 10.1016/j.vaccine.2008.10.064. Epub 2008 Nov 11.
10
Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix).
BioDrugs. 2008;22(6):387-402. doi: 10.2165/0063030-200822060-00005.
Zotero 插件